Glaucoma Treatment
Glaucoma Disease » Glaucoma Treatment » U.S. Rep. Barney Frank Introduces Medicinal Marijuana Bill

U.S. Rep. Barney Frank Introduces Medicinal Marijuana Bill

Question:

      Washington, D.C. — On November 10, U.S. Representative Barney Frank introduced H.R. 2618, which would allow doctors to prescribe marijuana to patients in need, by placing marijuana into a less restrictive schedule of the Controlled Substances Act and establishing a mechanism for production and distribution of marijuana.

Amazing that Barney Frank introduced anything that is even remotely related to AIDS.  Why doesnt he introduce a bill to clean up the NIH? Hundreds of millions of $s are being spent on AIDS research by this institution with scant results.  Even worse, the farce going on at Office of AIDS Research with the advisory panels is rubbing salt to the wounds. Enis

Response:

– Hide quoted text — Show quoted text -FOR IMMEDIATE RELEASE NOVEMBER 13, 1995 Rep. Barney Frank Re-Introduces Medicinal Marijuana Bill Previously Co-Sponsored by Rep. Newt Gingrich CONTACT:  Robert Kampia, director of government relations, Marijuana Policy Project (MPP) (202)462-5747 [...]       It remains to be seen whether Rep. Newt Gingrich will co-sponsor Rep. Frank’s bill. CONTACT:  Robert Raben, Office of U.S. Rep. Barney Frank (202)225-5931       Tony Blankley, Office of U.S. Rep. Newt Gingrich (202)225-0600 HOW TO SUPPORT THE MARIJUANA POLICY PROJECT:

I contacted this group today and they told me that they have applied for a 501 (C) (4) non-profit status but they do not have one now. I thanked them for posting the information about Rep. Frank’s bill. After they posted the above article I told them that advertising and fundraising was not permitted on misc.health.aids. They understood that and agreed to not solicit funds here again in future posts. BTW, they told me that Nobel Laureate Kary Mullis (the inventor of PCR) is on the board of NORML (The National Organization for the Reform of Marijuana Laws)!          James M. Scutero, original proponent of misc.health.aids          misc.health.aids homepage: http://www.panix.com/~jscutero    MISC.HEALTH.AIDS * HIV/AIDS TALK ONLY * NO COMMERCIALS * NO MODERATORS

Response:

FOR IMMEDIATE RELEASE NOVEMBER 13, 1995 Rep. Barney Frank Re-Introduces Medicinal Marijuana Bill Previously Co-Sponsored by Rep. Newt Gingrich CONTACT:  Robert Kampia, director of government relations, Marijuana Policy Project (MPP) (202)462-5747        Washington, D.C. — On November 10, U.S. Representative Barney Frank introduced H.R. 2618, which would allow doctors to prescribe marijuana to patients in need, by placing marijuana into a less restrictive schedule of the Controlled Substances Act and establishing a mechanism for production and distribution of marijuana. This bill is nearly identical to a 1981 bill — H.R. 4498 — which was co-sponsored by a bipartisan coalition of 84 members of the House, including U.S. Representative Newt Gingrich. (The 1981 bill never left committee.)        The need for Rep. Frank’s legislation arises from the fact that marijuana is presently classified as a Schedule I controlled substance, which forbids doctors from prescribing it under any circumstances. Even cocaine and morphine are presently in Schedule II — which allows tightly controlled prescriptive access — into which H.R. 2618 would place marijuana.        "Thousands of patients have found marijuana beneficial as part of the treatment for cancer, AIDS, glaucoma, multiple sclerosis, and other ailments," said MPP Director of Government Relations Robert Kampia. "Polls indicate that 80% of U.S. voters support the use of marijuana for medicine, and 36 states have already passed legislation recognizing marijuana’s medicinal value. However, legal access remains stymied by the federal government’s overriding prohibition."        "Presently, only eight patients in the entire country now have permission to use marijuana, through a program closed to all new applicants since 1992. All other patients presently using marijuana are considered criminals, subject to arrest and imprisonment," explained Kampia. "Efforts to resolve the matter through the FDA drug-approval process have consistently been stymied by the National Institute on Drug Abuse’s reluctance to provide the marijuana needed for the required clinical research. We must now try the legislative route."        "This legislation would finally allow doctors to decide what is best for their patients," said Kampia. "Presently, the federal government ties doctors’ hands and condemns patients to unnecessary suffering."        It remains to be seen whether Rep. Newt Gingrich will co-sponsor Rep. Frank’s bill. CONTACT:  Robert Raben, Office of U.S. Rep. Barney Frank (202)225-5931        Tony Blankley, Office of U.S. Rep. Newt Gingrich (202)225-0600 HOW TO SUPPORT THE MARIJUANA POLICY PROJECT: To support the MPP’s work and receive the bimonthly newsletter, "Marijuana Policy Report," please send $25.00 annual membership dues to: Marijuana Policy Project (MPP) P.O. Box 77492 Capitol Hill Washington, D.C. 20013 202-462-5747   TEL 202-232-0442   FAX http://www.mpp.org/~mpp/ —  end  –

Response:

Related Posts

Write a comment